When Lobectomy Is Out: Selecting Treatment for Stage 1 Non-Small Cell Lung Cancer in High-Risk Patients

We may be living in a world where people survive cancer but die early because they don’t have access to nutritious food.

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to “wake up” the immune system against cancer.

Improving quality of life for patients with non-small cell lung cancer requires a holistic, value-based care approach that considers treatment side effects and patient preferences, not just survival, according to study findings published in Journal of Clinical Oncology.

My grandfather died in June 2017 from prostate cancer in rural Franklin County, Illinois, two and a half hours from the nearest major cancer center.